\(
\def\WIPO{World Intellectual Property Organisation}
\)
Patent Portfolios and Pharmaceuticals: A European Perspective
2023
G 25 PAT.A
Available at WIPO Library
格式
| 格式 | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS | |
题名
Patent Portfolios and Pharmaceuticals: A European Perspective
描述
XI, 257 pages ; 24 cm
国际图书编号
9791221100389 Print
替代索书号
G 25 PAT.A
摘要
This book describes undertakings’ tendency today to protect their intangible technical property through a portfolio of patents. Such trend is in part triggered by the very same feature of modern innovation which, being today complex and cumulative, demands for more patents to efficiently protect its inventive trail. At the same time, undertakings have come to realize that the patent portfolio vests its owner with a set of strategic advantages which exceed by far the mere excluding powers conferred by the patents contained therein. The latter circumstance igniting a vicious circle, whereby firms patent more and more. While fully compliant with patent law, portfolios may cause dangerous drawbacks for competing innovators, as the cluster builds up entry barriers sometimes very hard to surpass. This all the more so in the pharmaceutical sector where the portfolios can be successfully implemented against both originators and generic companies, hence threatening the entrance of generic drugs and biosimilars. The book provides for an in-depth analysis of patent law substantive – as well as procedural – provisions allowing to build patent portfolios in the pharmaceutical sector. It then moves to analyze cases where patent portfolios have been implemented to the goal of foreclosing access to competitors, and the different outcomes provided with by patent law and by competition law.
附注
Includes bibliographical references
格式化内容附注
Chapter I: The collapse of the one-innovation one-patent model and the raise of patent portfolios
Chapter II: Derivative patents as a tool to build patent portfolios
Chapter III: The protection of second therapeutical use inventions in the practice of the European patent office
Chapter IV: The construction of patent clusters through divisional applications
Chapter V: Patent portfolios in the pharmaceutical sector: implications from the uncertain contours of second medical use patents
Chapter VI: Patent portfolios and competition law
Chapter VII: Concluding remarks
Bibliography
Chapter II: Derivative patents as a tool to build patent portfolios
Chapter III: The protection of second therapeutical use inventions in the practice of the European patent office
Chapter IV: The construction of patent clusters through divisional applications
Chapter V: Patent portfolios in the pharmaceutical sector: implications from the uncertain contours of second medical use patents
Chapter VI: Patent portfolios and competition law
Chapter VII: Concluding remarks
Bibliography
出版信息
Torino : G. Giappichelli Editore, 2023.
语言
eng
记录出处